MBK’s CNS woes underline private equity problems in TaiwanDanny LeungFeb 12, 2017MBK Partners has seen its sale of a 60% stake in CNS fall through again, underscoring the difficulty for private equity firms looking to exit Taiwan in the face of regulatory challenges.
